Four Indonesian hospitals, among them Siloam Hospitals Group, joined the International Health Tourism and Services Expo in Dhaka from 7 to 9 May 2026, and the trip closed with a deal aimed at routing Bangladeshi patients toward Indonesia. Bangladesh Post reported that the Embassy of the Republic of Indonesia in Dhaka, known as KBRI Dhaka, arranged and backed the delegation as part of Indonesia’s economic diplomacy in the health sector. The agreement was signed on 8 May 2026 between Siloam Hospitals Group and a Bangladeshi medical travel facilitator, and it sets out to draw patients from Bangladesh, a country of more than 170 million people, toward Indonesia as a medical destination.
That last figure is the whole story. Bangladesh is one of the largest single source markets in South Asia, and its patients already travel in volume for care that is faster, cheaper, or simply not on offer at home. Indonesia now wants that outbound flow, with an embassy opening doors and a hospital group signing the deal. This is medical tourism as economic diplomacy. A state is trying to turn goodwill into booked patients.
Indonesian hospital delegation in Dhaka
Siloam Hospitals Group, a large private operator, travelled alongside three national public hospitals: the Dr Cipto Mangunkusumo National Referral Hospital, known as RSCM; the Harapan Kita National Cardiovascular Center; and the Dharmais National Cancer Hospital. That line-up is deliberate. Bangladesh Post reported that KBRI Dhaka set up the visit to show off Indonesian medical services and to build on an existing health pact between the two countries.
One private group beside three specialist public centres tells a buyer what Indonesia wants to sell. Heart disease and cancer are high-value service lines, the kind of complex care that pushes patients across borders when waiting lists or skills fall short at home. Set those centres next to a private group that can handle flights, language, and aftercare, and you have a clear offer to a South Asian patient. Indonesia is not pitching wellness here. It is pitching hospitals.
Economic diplomacy and the ministry meeting
Bangladesh Post reported that at the Business Gathering and Networking Session on 7 May, the Ambassador of Indonesia to Bangladesh, Listyowati, said the event was about “building bridges and strengthening partnerships between the two countries.” She cast the visit as a way to link hospitals in both countries through shared training and expertise, and as a chance to open new work in medical services, health tourism, and staffing.
The envoy and the hospital delegates also paid a courtesy call on the Secretary of the Health Services Division at Bangladesh’s Ministry of Health and Family Welfare. They talked over ways to deepen bilateral health ties and put real programmes in place. Talks at ministry level matter here. Outbound medical travel runs on referral paths, insurance rules, and visa terms that sit with government, not with any single hospital.
Facility visits and the signed agreement
The delegation also toured several hospitals in Bangladesh, among them national heart and neuroscience institutes and two private hospitals, a normal step in building the referral ties that move patients. The one hard output of the visit was the deal signed on 8 May 2026 between Siloam Hospitals Group and the Bangladeshi facilitator, which seeks to send patients from Bangladesh to Indonesian providers.
That deal is where the diplomacy meets the facilitator, and the facilitator is worth a hard look. A facilitator is a middleman who markets a place and books the patient, and its pull is volume, not the outcome on the ward. It sells trust and logistics; its risk is that it trades on visibility rather than on real quality. For Siloam Hospitals Group, the channel only pays off if the patients it sends are treated well enough to spread word of mouth, because a market of 170 million rewards a good name and punishes a bad result faster than any brochure can mend.
HTN analysis: what to watch
The move is a state-backed push by Indonesia into one very large source market, and that focus is both its strength and its risk. Betting the plan on one neighbour of 170 million works while relations stay warm and bites when a visa rule, a currency swing, or a cold spell shifts the terms. The health pact and the meetings are scaffolding; the signed deal is the first load-bearing beam. The rest is intent until patients move.
Three things will show whether it converts. First is volume, whether the Bangladeshi facilitator really sends patients to Siloam Hospitals Group across 2026 and 2027, and in which fields. Second is spread, whether RSCM, Harapan Kita, and Dharmais sign channels of their own rather than leaving one private group to carry the trade. Third is follow-through, whether the ministry talks yield real programmes on visas, referrals, and staff exchange, since those are the levers that turn a photographed handshake into a lasting patient corridor.
